Severe hyperkalemia requiring hospitalization: Predictors of mortality

Critical Care

Volumn 16, Issue 6, 2012, Pages

  An, Jung N ^a   Lee, Jung P ^a,b   Jeon, Hee J ^a   Kim, Do H ^a   Oh, Yun K ^a,b   Kim, Yon S ^a   Lim, Chun S ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; INFECTION; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC ACIDOSIS; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; ACIDOSIS; ACUTE DISEASE; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ACIDOSIS; ACUTE DISEASE; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; POTASSIUM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84869209192     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11872     Document Type: Article

References (36)

1. Giebisch G. Renal potassium transport: mechanisms and regulation. Am J Physiol 1998, 274:F817-F833.
2. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol 2004, 43:155-161. 10.1016/j.jacc.2003.06.021, 14736430.
3. Hoskote SS, Joshi SR, Ghosh AK. Disorders of potassium homeostasis: pathophysiology and management. J Assoc Physicians India 2008, 56:685-693.
4. Perazella MA, Mahnensmith RL. Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 1997, 12:646-656. 10.1046/j.1525-1497.1997.07128.x, 1497179, 9346463.
5. Tran HA. Extreme hyperkalemia. South Med J 2005, 98:729-732. 10.1097/01.SMJ.0000149407.51134.77, 16108244.
6. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?. Arch Intern Med 1998, 158:26-32. 10.1001/archinte.158.1.26, 9437375.
7. Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987, 147:867-869. 10.1001/archinte.1987.00370050063011, 3579440.
8. Borra S, Shaker R, Kleinfeld M. Hyperkalemia in an adult hospitalized population. Mt Sinai J Med 1988, 55:226-229.
9. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998, 158:917-924. 10.1001/archinte.158.8.917, 9570179.
10. Mahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev 2005, CD003235.
11. Shemer J, Modan M, Ezra D, Cabili S. Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci 1983, 19:659-661.
12. Ohmae M, Rabkin SW. Hyperkalemia-induced bundle branch block and complete heart block. Clin Cardiol 1981, 4:43-46. 10.1002/clc.4960040110, 7226590.
13. Spodick DH. Effects of severe hyperkalemia. Am Heart Hosp J 2008, 6:68. 10.1111/j.1751-7168.2008.07777.x, 18256562.
14. Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 2000, 18:721-729. 10.1053/ajem.2000.7344, 11043630.
15. Ettinger PO, Regan TJ, Oldewurtel HA. Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 1974, 88:360-371. 10.1016/0002-8703(74)90473-6, 4604546.
16. Gennari FJ. Disorders of potassium homeostasis. Hypokalemia and hyperkalemia. Crit Care Clin 2002, 18:273-288. 10.1016/S0749-0704(01)00009-4, 12053834.
17. Jackson MA, Lodwick R, Hutchinson SG. Hyperkalaemic cardiac arrest successfully treated with peritoneal dialysis. Br Med J 1996, 312:1289-1290.
18. Voelckel W, Kroesen G. Unexpected return of cardiac action after termination of cardiopulmonary resuscitation. Resuscitation 1996, 32:27-29. 10.1016/0300-9572(96)00954-9, 8809916.
19. Niemann JT, Cairns CB. Hyperkalemia and ionized hypocalcemia during cardiac arrest and resuscitation: possible culprits for postcountershock arrhythmias?. Ann Emerg Med 1999, 34:1-7. 10.1016/S0196-0644(99)70265-9, 10381988.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. 10.1186/cc2872, 522841, 15312219.
21. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245.
22. Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med 2004, 27:153-160. 10.1016/j.jemermed.2004.04.006, 15261358.
23. Webster A, Brady W, Morris F. Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration. Emerg Med J 2002, 19:74-77. 10.1136/emj.19.1.74, 1725789, 11777886.
24. Yu AS. Atypical electrocardiographic changes in severe hyperkalemia. Am J Cardiol 1996, 77:906-908. 10.1016/S0002-9149(97)89197-7, 8623755.
25. Beroniade V, Cornielle L, Haraoui B. Indomethacin-induced inhibition of prostaglandin with hyperkalemia. Ann Intern Med 1979, 91:499-500.
26. DuBose TD. Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 1997, 51:591-602. 10.1038/ki.1997.85, 9027745.
27. Wrenger E, Müller R, Moesenthin M, Welte T, Frölich JC, Neumann KH. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. Br Med J 2003, 327:147-149.
28. Ramadan FH, Masoodi N, El-Solh AA. Clinical factors associated with hyperkalemia in patients with congestive heart failure. J Clin Pharm Ther 2005, 30:233-239. 10.1111/j.1365-2710.2005.00638.x, 15896240.
29. Henz S, Maeder MT, Huber S, Schmid M, Loher M, Fehr T. Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant 2008, 23:3939-3945. 10.1093/ndt/gfn380, 18614817.
30. Sato A, Saruta T. Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res 2004, 27:303-310. 10.1291/hypres.27.303, 15198476.
31. Stevens MS, Dunlay RW. Hyperkalemia in hospitalized patients. Int Urol Nephrol 2000, 32:177-180. 10.1023/A:1007135517950, 11229629.
32. Hu Y, Carpenter JP, Cheung AT. Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency. Anesth Analg 2002, 95:39-41. 10.1097/00000539-200207000-00006, 12088939.
33. Cruz CS, Cruz AA, Marcilio de Souza CA. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone. Nephrol Dial Transplant 2003, 18:1814-1819. 10.1093/ndt/gfg295, 12937229.
34. Paice B, Gray JM, McBride C, Donnelly T, Lawson DH. Hyperkalemia in patients in hospital. Br Med J 1983, 286:1189-1192.
35. Takaichi K, Takemoto F, Ubara Y, Mori Y. Analysis of factors causing hyperkalemia. Intern Med 2007, 46:823-829. 10.2169/internalmedicine.46.6415, 17575373.
36. Evans K, Reddan DN, Szczech LA. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. Semin Dial 2004, 17:22-29. 10.1111/j.1525-139X.2004.17110.x, 14717808.